0
Original Research |

A prospective study of estimated glomerular filtration rate and outcomes in patients with atrial fibrillation: The Loire Valley Atrial Fibrillation Project

Amitava Banerjee, MPH, DPhil; Laurent Fauchier, MD, PhD; Patrick Vourc'h, PhD; Christian R. Andres, MD, PhD; Sophie Taillandier, MD; Jean Michel Halimi, MD, PhD; Gregory Y. H. Lip, MD
Author and Funding Information

University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham B18 7QH, UK (a.banerjee.1@bham.ac.uk, g.y.h.lip@bham.ac.uk) (Banerjee, Lip); Service de Nephrologie-Immunologie Clinique, Hðpital Bretonneau and Université François Rabelais, Tours, France (halimi@med.univ-tours.fr) (Halimi); Laboratoire de Biochimie et Biologie moléculaire, Hôpital Bretonneau, Centre Hospitalier régional et Universitaire de Tours (vourch@med.univ-tours.fr, andres@med.univ-tours.fr) (Vourc'h, Andres); Service de Cardiologie, Pôle Coeur Thorax Vasculaire, Centre Hospitalier, Universitaire Trousseau et Faculté de Médecine, Université François Rabelais, Tours, France (lfau@med.univ-tours.fr, sofi.taillandier@yahoo.fr) (Fauchier, Taillandier)

Corresponding author: Gregory Y. H. Lip, MD, University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham B18 7QH, UK; e-mail: g.y.h.lip@bham.ac.uk

Drs Halimi and Lip are joint senior authors.


Chest. 2013. doi:10.1378/chest.13-2103
Text Size: A A A
Published online

Abstract

Background  Patients with chronic kidney disease (CKD) are more likely to develop atrial fibrillation(AF) than individuals with normal renal function, and are more likely to suffer ischaemic stroke(IS)/thromboembolism(TE). No prior study has considered the impact of eGFR on bleeding. We investigated the relationship of eGFR to IS/TE, mortality and bleeding in an AF population, unrestricted by age or comorbidity.

Methods  Patients with non-valvular AF (NVAF) were stratified into five categories according to eGFR(ml/min/1.73 m2): ≥90,60-89,30-59,15-29 and <15, analysing risk factors, all-cause mortality, bleeding and IS/TE. Of 8962 eligible individuals, 5912 had NVAF and available serum creatinine data, with 14499 patient-years of follow-up.

Results  In non-anticoagulated and anticoagulated individuals, the incidence rates of IS/TE were 7.4 and 7.2 per 1000 person-years, respectively. Rates of all-cause mortality were 13.4 and 9.4 per 1000 person-years, respectively, and of major bleeding, 6.2 and 9.0 per 1000 person-years, respectively.Rates increased with decreasing eGFR with IS/TE rates being lower in individuals receiving OAC. eGFR was not an independent predictor of IS/TE on multivariate analyses. When the benefit of IS reduction is balanced against the increased risk of haemorrhagic stroke, the net clinical benefit (NCB) was clearly positive in favour of OAC use.

Conclusion  Incidence rates of IS/TE, mortality and bleeding increased with reducing eGFR, across the whole range of renal function. OAC use was associated with a lower incidence of IS/TE and mortality at 1 year, compared with non-anticoagulated individuals in all categories of renal function as measured by eGFR. The NCB balancing IS against serious bleeding was positive, in favour of OAC use amongst patients with renal impairment.


Sign In to Access Full Content

Want to Purchase a Subscription?

New to CHEST? Become an ACCP member to receive a full subscription to both the print and online editions.
Want to access your Institution's subscription?
Sign in to your individual user account while you are actively authenticated on this website via your institution (Learn more about institutional authentication). We will then sustain your personal access to their content/subscription for 90 days, after which you can repeat this process.

Sign In to Access Full Content

Want to Purchase a Subscription?

New to CHEST? Become an ACCP member to receive a full subscription to both the print and online editions.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
CHEST Collections
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543